BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 6150627)

  • 1. Trimepranol, a Czechoslovak-made beta blocker, in the treatment of acute myocardial infarction.
    Charvát J; Pavlovic J; Fiserová J
    Acta Univ Carol Med (Praha); 1984; 30(1-2):117-23. PubMed ID: 6150627
    [No Abstract]   [Full Text] [Related]  

  • 2. [Hemodynamic effects and tolerance for trimepranol in acute myocardial infarct].
    Pavlovic J; Charvát J; Fiserová J
    Vnitr Lek; 1982 Dec; 28(12):1191-7. PubMed ID: 6130651
    [No Abstract]   [Full Text] [Related]  

  • 3. [The advantage of hypertension therapy with a once-daily beta-blocker-diuretic combination].
    Teufel W; Glocke M
    Med Klin; 1981 Aug; 76(18):513-5. PubMed ID: 6116170
    [No Abstract]   [Full Text] [Related]  

  • 4. [The effect of the beta-blockers nadolol and metipranolol in patients with thyrotoxicosis].
    Vavrejnová V; Felt V; Nedvídková J
    Cas Lek Cesk; 1985 Oct; 124(43):1320-3. PubMed ID: 2867827
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical and metabolic effects of metipranolol].
    Cottini E; Barbanti P; Lunetta M; Dimaiuta G; Emma V; Sorrentino F
    Boll Soc Ital Cardiol; 1981; 26(10):1341-8. PubMed ID: 6129875
    [No Abstract]   [Full Text] [Related]  

  • 6. Plasma catecholamine concentration in hypertensive subjects with chronic renal failure before and during treatment with the beta-receptor blocking drug metipranolol.
    Planz G; Haass H; Lamberts B
    Int J Clin Pharmacol Ther Toxicol; 1982 Oct; 20(10):469-73. PubMed ID: 6128312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Changes in the efficiency of the left heart ventricle during treatment with metipranolol (Trimepranol Spofa)].
    Smíd J; Hůla J; Kubín Z
    Vnitr Lek; 1983 Apr; 29(4):325-31. PubMed ID: 6135276
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effect of prolonged administration of beta-blockers on the hemodynamics of patients who have sustained a myocardial infarct].
    Malek I; Stanek V; Gebauerova M; Iedlichka I
    Kardiologiia; 1985 Sep; 25(9):48-52. PubMed ID: 2867243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of sudden death in acute myocardial ischaemia.
    Fejfar Z; Vrána M; Horák O; Trcka V; Kristan L; Blazek Z; Korál V; Sychra T
    Czech Med; 1980; 3(1):28-35. PubMed ID: 6102022
    [No Abstract]   [Full Text] [Related]  

  • 10. [Congestive cardiomyopathy--trimepranol induced haemodynamic changes (author's transl)].
    Jebavý P; Málek I; Beránek I
    Cas Lek Cesk; 1982 Jan; 121(2):45-51. PubMed ID: 6120764
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effect of metipranolol (Trimepranol Spofa) on changes in selected hemodynamic indicators during physical exercise. I. Dynamic loading].
    Smíd J; Jeschke J; Zeman V; Kubín Z
    Vnitr Lek; 1983 Sep; 29(9):862-8. PubMed ID: 6138899
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effect of metipranolol (Trimepranol Spofa) on changes in selected hemodynamic indicators during physical exercise. II. Isometric loading].
    Smíd J; Kubín Z
    Vnitr Lek; 1983 Sep; 29(9):869-75. PubMed ID: 6138900
    [No Abstract]   [Full Text] [Related]  

  • 13. [Hypertrophic obstructive cardiomyopathy-trimepranol-induced haemodynamic changes (author's transl)].
    Jebavý P; Gebauerová M; Beránek I
    Cas Lek Cesk; 1982 Feb; 121(7):198-205. PubMed ID: 6122504
    [No Abstract]   [Full Text] [Related]  

  • 14. [Advantages of hypertension therapy with the once daily administration of a combination of beta-blocker and diuretic. Experiences with the self-measurement of blood pressure].
    Teufel W; Glocke M
    Ther Ggw; 1981 May; 120(5):470-85. PubMed ID: 6112801
    [No Abstract]   [Full Text] [Related]  

  • 15. [Thermodiagnostic assessment of trimepranol effects in arterial hypertension (author's transl)].
    Kaderávek F
    Cas Lek Cesk; 1980; 119(8):236-41. PubMed ID: 6103754
    [No Abstract]   [Full Text] [Related]  

  • 16. An experimental contribution to the treatment of acute myocardial infarction.
    Vrána M; Hess L; Vránová Z; Fejfar Z
    Czech Med; 1987; 10(3):142-55. PubMed ID: 2889585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Crystepin T (Trimecryton). Multi-center evaluation of a anti-hypertensive agent containing a beta blocker].
    Mayer O; Cepelák V; Cícha Z; Kokaisl V; Mádle A; Mazanec J; Moses K; Vácha J
    Cas Lek Cesk; 1983 Jul; 122(29):906-12. PubMed ID: 6137281
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effect of beta-blocking agents talinolol and metipranolol in patients with thyrotoxicosis (author's transl)].
    Nedvídková J; Cenková V; Felt V
    Cas Lek Cesk; 1980 Jul; 119(27-28):749-51. PubMed ID: 6107177
    [No Abstract]   [Full Text] [Related]  

  • 19. [Cardioselective beta blocker methoprolol evaluation in patients suffering from myocardial infarction (author's transl)].
    Málek I; Waagstein F; Hjalmarson AC
    Cas Lek Cesk; 1977 Oct; 116(42):1303-7. PubMed ID: 589646
    [No Abstract]   [Full Text] [Related]  

  • 20. Esmolol for tight heart rate control in patients with STEMI: Design and rationale of the beta-blocker in acute myocardial infarction (BEAT-AMI) trial.
    Er F; Erdmann E; Nia AM; Dahlem KM; Biesenbach E; Herrfurth T; Taghiyev Z; Le MT; Hellmich M; Kuhr K; Caglayan E; Gassanov N
    Int J Cardiol; 2015; 190():351-2. PubMed ID: 25939126
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.